Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Logothetis
Eleni Efstathiou
Fil Manuguid
Peter Kirkpatrick

Showing results (121-130 of 476) with videos related to

Pageof 48
Sort By:
Nature Reviews. Drug Discovery|September 1, 2011
BelataceptFlavio Vincenti, Argyris Dritselis, Peter Kirkpatrick
Nature Reviews. Drug Discovery|March 2, 2012
TafamidisGerard Said, Seden Grippon, Peter Kirkpatrick
Nature Reviews. Drug Discovery|February 6, 2004
OxaliplatinJoanne Graham, Mohamed Mushin, Peter Kirkpatrick
Nature Reviews. Drug Discovery|March 26, 2004
Memantine hydrochlorideAndrea Witt, Nancy Macdonald, Peter Kirkpatrick
Nature Reviews. Drug Discovery|December 24, 2005
TipranavirCharles Flexner, Guy Bate, Peter Kirkpatrick
Neurosurgical Focus|July 7, 2007
Surgery for brain edemaPeter Hutchinson, Ivan Timofeev, Peter Kirkpatrick
Journal of the National Cancer Institute|February 27, 2009
Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancerDimitra Tsavachidou, Timothy J McDonnell, Sijin Wen, et al.
Nature Medicine|March 28, 2017
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancerJianjun Gao, John F Ward, Curtis A Pettaway, et al.
Nature Reviews. Drug Discovery|July 31, 2010
DenosumabRené Rizzoli, Uma Yasothan, Peter Kirkpatrick
Nature Reviews. Drug Discovery|January 4, 2011
PegloticaseNaomi Schlesinger, Uma Yasothan, Peter Kirkpatrick
Pageof 48

Showing results (121-130 of 476) with videos related to

Sort By:
Pageof 48
Nature Reviews. Drug Discovery|September 1, 2011
BelataceptFlavio Vincenti, Argyris Dritselis, Peter Kirkpatrick
Nature Reviews. Drug Discovery|March 2, 2012
TafamidisGerard Said, Seden Grippon, Peter Kirkpatrick
Nature Reviews. Drug Discovery|February 6, 2004
OxaliplatinJoanne Graham, Mohamed Mushin, Peter Kirkpatrick
Nature Reviews. Drug Discovery|March 26, 2004
Memantine hydrochlorideAndrea Witt, Nancy Macdonald, Peter Kirkpatrick
Nature Reviews. Drug Discovery|December 24, 2005
TipranavirCharles Flexner, Guy Bate, Peter Kirkpatrick
Neurosurgical Focus|July 7, 2007
Surgery for brain edemaPeter Hutchinson, Ivan Timofeev, Peter Kirkpatrick
Journal of the National Cancer Institute|February 27, 2009
Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancerDimitra Tsavachidou, Timothy J McDonnell, Sijin Wen, et al.
Nature Medicine|March 28, 2017
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancerJianjun Gao, John F Ward, Curtis A Pettaway, et al.
Nature Reviews. Drug Discovery|July 31, 2010
DenosumabRené Rizzoli, Uma Yasothan, Peter Kirkpatrick
Nature Reviews. Drug Discovery|January 4, 2011
PegloticaseNaomi Schlesinger, Uma Yasothan, Peter Kirkpatrick
Pageof 48